Frontlight ResearchEarly access
Trial site
Mays Cancer Center, UT Health San Antonio
- 3running trials
- 9closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Diffuse large B-cell lymphoma2 trials
- Glioblastoma2 trials
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 14 trials
- Early phase 12 trials
- Phase 22 trials
- Phase 31 trial
- Status
- Completed5 trials
- Recruiting3 trials
- Withdrawn3 trials
- Terminated1 trial
- Lead sponsor
- The University of Texas Health Science Center at San Antonio9 trials
- Anwaar Saeed1 trial
- Janssen Research & Development, LLC1 trial
- Virginia G. Kaklamani1 trial
Running trials
Recruiting
Recruiting
Recruiting
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Glioblastoma1 recruiting
- Liver and biliary tract cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Withdrawn
Withdrawn
Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy
Withdrawn
Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer
Completed
Completed
Terminated
Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
Completed
Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026